Breast Neoplasms, Male - 25 Studies Found
Completed |
: Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer :
|
Completed |
: Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer :
|
Completed |
: Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer :
|
Withdrawn |
: Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer :
|
Active, not recruiting |
: FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer :
|